Literature DB >> 3037905

Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy-type I (Portuguese, Andrade).

J Sequeiros, M J Saraiva.   

Abstract

In a Portuguese-American family with hereditary amyloid neuropathy (familial amyloidotic polyneuropathy), onset was in the seventh decade in all affected relatives. Another unusual characteristic was their origin from the Portuguese island of Madeira. In spite of this, the mutant transthyretin (TTRMet30) (the same variant prealbumin that is the circulating precursor of AFP protein in the classic Portuguese patients) could be found in the propositus' plasma. In addition, three other asymptomatic relatives (ages 90, 73, and 48) were shown to carry the mutation. Late onset and incomplete penetrance, at a clinical level, raise problems for presymptomatic detection of mutant TTR, as these tend to cluster in families. When counseling asymptomatic heterozygotes, we must consider intra-familial correlation in age-of-onset, and the distribution of age-of-onset including age of unaffected heterozygotes. This family poses interesting questions regarding pathogenesis of this degenerative process and the influence of other genetic factors, such as modifiers, epistasis, and polymorphism of the TTR genes or their regulators. A cis-effect of a gene linked to the mutant gene, decreasing the synthesis of the mutant TTR and keeping a sufficient amount of the normal one in circulation, or producing some cofactor for TTR, could also explain late onset and apparently incomplete penetrance; the occasional finding of classic forms in these families would be the result of recombinatory events.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037905     DOI: 10.1002/ajmg.1320270213

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis.

Authors:  Ana Martins da Silva; Sara Cavaco; Joana Fernandes; Raquel Samões; Cristina Alves; Márcio Cardoso; Jeffery W Kelly; Cecília Monteiro; Teresa Coelho
Journal:  J Neurol       Date:  2017-12-05       Impact factor: 4.849

2.  Death anxiety and symbolic immortality in relatives at risk for familial amyloid polyneuropathy type I (FAP I, ATTR V30M).

Authors:  Paula I Santos; Eurico Figueiredo; Inês Gomes; Jorge Sequeiros
Journal:  J Genet Couns       Date:  2010-08-03       Impact factor: 2.537

Review 3.  A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected.

Authors:  T Coelho; A Sousa; E Lourenço; J Ramalheira
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

4.  A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.

Authors:  Miguel Alves-Ferreira; Teresa Coelho; Diana Santos; Jorge Sequeiros; Isabel Alonso; Alda Sousa; Carolina Lemos
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

5.  A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.

Authors:  K Yamamoto; S Ikeda; N Hanyu; S Takeda; N Yanagisawa
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

6.  Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study.

Authors:  M M Reilly; H Staunton; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

7.  Transthyretin gene mutations in British and French patients with amyloid neuropathy.

Authors:  K Bhatia; M Reilly; D Adams; M B Davis; C H Hawkes; P K Thomas; G Said; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

8.  Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.

Authors:  Hartmut H-J Schmidt; Fabio Barroso; Alejandra González-Duarte; Isabel Conceição; Laura Obici; Denis Keohane; Leslie Amass
Journal:  Muscle Nerve       Date:  2016-09       Impact factor: 3.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.